Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond.

Cells · 2021 · PMC8073599 · PMID 33924019

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Indeed, a preliminary analysis of the minority of individuals in CANTOS for whom genetic consent and DNA were available showed a trend towards greater efficacy of IL-β inhibition in those with DNMT3a or TET2 CHIP [ 122 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.